Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells

Journal of Molecular Endocrinology

Volumn 49, Issue 2, 2012, Pages 153-163

  Tsui, Ke Hung ^a   Chang, Ying Ling ^b   Feng, Tsui Hsia ^b   Chung, Li Chuan ^b   Lee, Tzu Yi ^b   Chang, Phei Lang ^a   Juang, Horng Heng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 6; MASPIN; MATRIPTASE; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN; PROTEIN; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES; SERPINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866428024     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0149     Document Type: Article

References (51)

1. Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF et al. 2006 Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131 1553-1560. (doi:10.1053/j.gastro.2006.09.015)
2. Baek KE, Yoon SR, Kim JT, Kim KS, Kang SH, Yang Y, Lim JS, Choi I, Nam MS, Yoon NM et al. 2009 Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancer. Clinica Chimica Acta 401 128-133. (doi:10.1016/j.cca.2008.12.008)
3. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M et al. 2003 The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Research 63 1731-1736.
4. Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ et al. 2005 The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Research 65 2330-2336. (doi:10.1158/0008-5472.CAN-04-3827)
5. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K et al. 1997 MIC-1, a novel macrophage inhibitory cytokine, is a divergentmember of the TGF-b superfamily. PNAS 94 11514-11519. (doi:10.1073/pnas.94. 21.11514)
6. Brown DA, Lindmark F, Stattin P, Balter K, Adami HO, Zheng SL, Xu J, Isaacs WB, Gronberg H, Breit SN et al. 2009 Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clinical Cancer Research 15 6658-6664. (doi:10.1158/1078-0432.CCR-08-3126)
7. Chen ML, Biliran HR, Bhagat S, Menckett J, Abrams J, Fridman R, ZachareasM& Sheng S 2003Maspin expression inhibits oesteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. PNAS 100 7847-7852. (doi:10.1073/pnas.1331360100)
8. Cheng JC, Chang HM & Leung PC 2011 Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression. Endocrinology 152 2987-2995. (doi:10.1210/en.2011-0059)
9. Chiu SC, Wang MJ, Yang HH, Chen SP, Huang SY, Chen YL, Lin SZ, Harn HJ & Pang CY 2011 Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells. BMC Cancer 11 146. (doi:10.1186/1471-2407-11-146)
10. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL & Juang HH 2011 Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Molecular Nutrition and Food Research 55 16666-16676. (doi:10.1002/mnfr. 201100328)
11. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL & Juang HH 2012 L-mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. American Journal of Physiology. Cell Physiology 302 C676-C685. (doi:10.1152/ajpcell.00180.2011)
12. Culig Z 2011 Cytokine disbalance in common human cancers. Biochimica et Biophysica Acta 1813 308-314. (doi:10.1016/j.bbamcr. 2010.12.010)
13. ForbsD, Thiel S, StellaMC, Sturzebecher A, Schweinitz A, Steinmetzer T, Sturzebecher J & Uhland K 2005 In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma. International Journal of Oncology 27 1061-1070.
14. George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, Small EJ & Kantoff PW 2005 The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480. Clinical Cancer Research 11 1815-1820. (doi:10.1158/1078-0432.CCR-04-1560)
15. Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, BentremDJ, Talamonti MS, BellRHet al. 2007Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. Journal of Surgical Research 138 163-169. (doi:10.1016/j.jss.2006.05.037)
16. Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ & Padalecki SS 2008 Maspin reduces prostate cancer metastasis to bone. Urologic Oncology 26 652-658. (doi:10.1016/j.urolonc. 2007.07.017)
17. Hromas R, Hufford M, Sutton J, Xu D, Li Y & Lu L 1997 PLAB, a novel placental bone morphogenetic protein. Biochimica et Biophysica Acta 1354 40-44. (doi:10.1016/S0167-4781(97)00122-X)
18. Iczkowski KA & Pantazis CG 2003 Overexpression of NSAID-activated gene product in prostate cancer. International Journal of Surgical Pathology 11 159-166. (doi:10.1177/106689690301100302)
19. Johnen H, Lin S, Kuffner T, Brown D, Tsai VWW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S et al. 2007 Tumor-induced anorexia and weight loss are mediated by the TGF-b superfamily cytokine MIC-1. Nature Medicine 13 1333-1340. (doi:10.1038/nm1677)
20. Kadara H, Schroeder CP, Lotan D, Pisano C & Lotan R 2006 Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis. Cancer Biology & Therapy 5 518-522. (doi:10.4161/cbt.5.5.2602)
21. Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF & Batra SK 2003 Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochemical and Biophysical Research Communications 305 598-604. (doi:10.1016/S0006-291X(03)00823-4)
22. Kawahara T, Ishiguro H, Hoshino K, Teranishi J, Miyoshi Y, Kubota Y & Uemura H 2010 Analysis of NSAID-activated gene 1 expression in prostate cancer. Urologia Internationalis 84 198-202. (doi:10.1159/000277599)
23. Lambert JR, Kelly JA, Shim M, Huffer WE, Nordeen SK, Baek SJ, Eling TE & Lucia S 2006 Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. Journal of Cellular Physiology 208 566-574. (doi:10.1002/jcp.20692)
24. Li X, Chen D, Ying S, Meng Y, Yang H, Landis-Piwowar KR, Li Y, Sarkar FH, Reddy GP, Dou QP et al. 2007 Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. Journal of Cellular Physiology 212 298-306. (doi:10.1002/jcp.21102)
25. Lin CY, Anders J, Johnson M, Sang QA & Dickson RB 1999 Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. Journal of Biological Chemistry 274 18231-18236. (doi:10.1074/jbc.274.26.18231)
26. Liu T, Bauskin AR, Zaunders J, Brown DA, Pankurst S, Russell PJ & Breit SN 2003 Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Research 63 5034-5040.
27. Mimeault M & Batra SK 2010 Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer. Journal of Cellular Physiology 224 626-635. (doi:10.1002/jcp.22196)
28. Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM et al. 2007 Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Research 67 5033-5041. (doi:10.1158/0008-5472.CAN-06-3332)
29. Pang ST, Hsieh WC, Chuang CK, Chao CH, Weng WH & Juang HH 2009 Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells. Journal of Molecular Endocrinology 42 205-214. (doi:10.1677/JME-08-0033)
30. Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S, Ke HZ, Zi H, Owen TA & Thompson DD 1998 Cloning and characterization of a novel member of the transforming growth factor-b/bone morphogenetic protein family. Journal of Biological Chemistry 273 13760-13767. (doi:10.1074/jbc.273.22.13760)
31. Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace D & Corey E 2003 Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 97 1211-1216. (doi:10.1002/cncr.11178)
32. Royuela M, Ricote M, Parsons MS, Garcia-Tunon I, Paniagua R & de Miguel MP 2004 Immunohistochemical analysis of the IL-6 family of cytokines and their receptor in benign, hyperplasic and malignant human prostate. Journal of Pathology 202 41-49. (doi:10.1002/path.1476)
33. Sanders AJ, Parr C, Davies G, Martin TA, Lane J, Mason MD & Jiang WG 2006 Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics & Oncology 6 39-48.
34. Selander KS, Steiner H, Cavarretta IT, Moser PL, Berger AP, Bektic J, Dietrich H, Zaki MH, Nakada M, Hobisch A et al. 2006 Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328. Prostate 66 1744-1752. (doi:10.1002/pros.20492)
35. Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK & Batra SK 2010 Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAKRhoA signaling pathway. Oncogene 29 1293-1302. (doi:10.1038/onc. 2009.420)
36. Shim M & Eling TE 2005 Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. Journal of Biological Chemistry 280 18636-18642. (doi:10.1074/jbc.M414613200)
37. Song Y, Oda Y, HoriM, Kuroiwa K, OnoM, Hosoi F, Basaki Y, Tokunaga S, Kuwano M, Naito S et al. 2010 N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Human Pathology 41 214-222. (doi:10.1016/j.humpath.2009.07.011)
38. Tsui KH, Chang PL, Lin HT & Juang HH 2004 Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells. Journal of Urology 172 2035-2039. (doi:10.1097/01.ju. 0000138053.78518.b2)
39. Tsui KH, Chang PL, Feng TH, Chung LC, Shu SY & Juang HH 2008a Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells. Anticancer Research 28 1977-1984.
40. Tsui KH, Feng TH, Hsieh WC, Chang PL & Juang HH 2008b Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells. Acta Pharmacologica Sinica 29 1334-1341. (doi:10. 1111/j.1745-7254.2008.00887.x)
41. Tsui KH, Feng TH, Lin YF, Chang PL & Juang HH 2011a p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cell. Prostate 71 62-70. (doi:10.1002/pros.21222)
42. Tsui KH, Lin YF, Chen YH, Chang PL & Juang HH 2011b Mechanisms by which interleukin-6 regulates prostate specific antigen gene expression in prostate LNCaP carcinoma cells. Journal of Andrology 32 383-393. (doi:10.2164/jandrol.109.009878)
43. Tsui KH, Chung LC, Feng TH, Chang PL & Juang HH 2012a Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells. International Journal of Cancer 130 2812-2823. (doi:10.1002/ijc.26284)
44. Tsui KH, Chung LC, Feng TH, Chang PL & Juang HH 2012b Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells. Prostate 72 1431-1442 (DOI: 10.1002/pros.22494). (doi:10.1002/pros.22494)
45. Tu LC, Yan X, Hood L & Lin B 2007 Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Molecular & Cellular Proteomics 6 575-588. (doi:10.1074/mcp.M600249-MCP200)
46. Wakchoure S, Swain TM, Hentunen TA, Bauskin AR, Brown DA, Breit SN, Vuopala KS, Harris KW & Selander KS 2009 Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Prostate 69 652-661. (doi:10.1002/pros.20913)
47. Wang X, Chrysovergis K, Bienstock RJ, Shim M & Eling TE 2012 The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo. Prostate 72 677-689. (doi:10.1002/pros.21471)
48. Watanabe M, Nasu Y, Kashiwakura Y, Kusumi N, Tamayose K, Nagai A, Sasano T, Shimasa T, Daida H & Kumon H 2005 Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth. Human Gene Therapy 16 699-710. (doi:10.1089/hum.2005. 16.699)
49. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ et al. 2003 Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. PNAS 100 3410-3415. (doi:10.1073/pnas.0530278100)
50. Wu SR, Cheng TS, Chen WC, Shyu HY, Ko CJ, Huang HP, Teng CH, Lin CH, Johnson MD, Lin CY et al. 2010 Matriptase is involved in ErbB-2-induced prostate cancer cell invasion. American Journal of Pathology 177 3145-3158. (doi:10.2353/ajpath.2010. 100228)
51. Zimmers TA, Jin X, Hsiao EC, Perez EA, Pierce RH, Chavin KD & Koniaris LG 2006 Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. Journal of Surgical Research 130 45-51. (doi:10.1016/j.jss.2005.07.036)